Loading...
Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a good buy at this time for a beginner investor with a long-term strategy. The stock shows weak financial performance, bearish technical indicators, and lacks positive catalysts or strong trading signals. The absence of news, analyst ratings, and significant insider or hedge fund activity further diminishes the appeal of this stock.
The stock is in a bearish trend with a negatively expanding MACD histogram (-0.102), an oversold RSI (15.266), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.149 and 0.872, while resistance levels are at 2.047 and 2.324. The stock is currently trading below key support levels, indicating further downside risk.
NULL identified. No recent news, insider activity, hedge fund activity, or congress trading data to suggest positive momentum.
Weak financial performance with a significant drop in net income (-37.97% YoY) and EPS (-97.35% YoY). The stock also lacks trading signals and is in a bearish technical setup.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income drop to -$2,347,302 (-37.97% YoY), and a significant decline in EPS (-97.35% YoY). Gross margin remained at 0%. Overall, the financials indicate poor performance and no growth trends.
No analyst ratings or price target changes available for SHPH.
